Arkolith/Insider Trading/EW/Form 4

Dahl Andrew M.

SVP, Corporate ControllerEdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$49K
Net Open-Market Flow
-$49K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2026Sell(S)568$86.08$49K15K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-005647) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML